BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23152000)

  • 21. [Changes in immune function of dendritic cells infected by recombinant adenovirus containing Her2/neu gene of extracellular and transmembrane domain proteins].
    Ma SD; Luo RC; Ding ZH; Lu F; Yuan CQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1184-7. PubMed ID: 16939917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced immune response to the melanoma antigen gp100 using recombinant adenovirus-transduced dendritic cells.
    Wan Y; Emtage P; Zhu Q; Foley R; Pilon A; Roberts B; Gauldie J
    Cell Immunol; 1999 Dec; 198(2):131-8. PubMed ID: 10648127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro induction of immune response by dendritic cells pulsed with TRAG-3-derived cytotoxic T lymphocyte epitope].
    Zhu B; Chen ZT; Cheng XM; Wu YZ
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):709-12. PubMed ID: 15733385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic cell generated from CD34+ hematopoietic progenitors can be transfected with adenovirus containing gene of HBsAg and induce antigen-specific cytotoxic T cell responses.
    Yang JY; Cao DY; Liu WC; Zhang HM; Teng ZH; Ren J
    Cell Immunol; 2006 Mar; 240(1):14-21. PubMed ID: 16875681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells.
    Schnurr M; Scholz C; Rothenfusser S; Galambos P; Dauer M; Röbe J; Endres S; Eigler A
    Cancer Res; 2002 Apr; 62(8):2347-52. PubMed ID: 11956095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of specific human cytotoxic T cells using dendritic cells transduced with an adenovector encoding rat epidermal growth factor receptor 2.
    Suresh K; Scheid E; Klotz L; Venkateswaran V; Gauldie J; Foley R
    Int J Oncol; 2011 Oct; 39(4):907-13. PubMed ID: 21769423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
    Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
    Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
    Wong JC; Bathina M; Fiscus RR
    J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells.
    Wang R; Lin F; Wang X; Gao P; Dong K; Zou AM; Cheng SY; Wei SH; Zhang HZ
    Cancer Gene Ther; 2008 Jun; 15(6):402-12. PubMed ID: 18340356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
    Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
    Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.
    Imura K; Ueda Y; Hayashi T; Itoh T; Shimizu K; Tamai H; Yano Y; Naito K; Kohara J; Nakane K; Matsuura Y; Takeda A; Takeda T; Kawai K; Yamagishi H
    Int J Oncol; 2006 Sep; 29(3):531-9. PubMed ID: 16865268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
    Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
    J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effect of RNA pool complexity on stimulatory capacity of RNA-pulsed dendritic cells.
    Javorovic M; Wilde S; Zobywalski A; Noessner E; Lennerz V; Wölfel T; Schendel DJ
    J Immunother; 2008 Jan; 31(1):52-62. PubMed ID: 18157012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro anti-tumor immune response induced by dendritic cells transfected with hTERT recombinant adenovirus.
    Chen L; Liang GP; Tang XD; Chen T; Cai YG; Fang DC; Yu ST; Luo YH; Yang SM
    Biochem Biophys Res Commun; 2006 Dec; 351(4):927-34. PubMed ID: 17097054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transfection with Livin and Survivin shRNA inhibits the growth and proliferation of non‑small cell lung cancer cells.
    Huang Q; Zeng Y; Lin H; Zhang H; Yang D
    Mol Med Rep; 2017 Nov; 16(5):7086-7091. PubMed ID: 28901499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Iida T; Yamaue H
    Int J Oncol; 2008 Feb; 32(2):459-66. PubMed ID: 18202769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic cells transfected with lentiviral vector-encoding hTERT peptide augment antitumor T cell response in vitro.
    Cui J; Cui L; Liu Q; Sun Q
    Mol Med Rep; 2012 Jan; 5(1):103-7. PubMed ID: 21971748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
    Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
    Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of antitumor cytotoxic lymphocytes using engineered human primary blood dendritic cells.
    Wu L; Zhang H; Jiang Y; Gallo RC; Cheng H
    Proc Natl Acad Sci U S A; 2018 May; 115(19):E4453-E4462. PubMed ID: 29674449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Livin mediates tumor cell invasion in the DU-145 cell line via NF-κB.
    Chen F; Yang D; Che X; Wang J; Li X; Zhang Z; Chen X; Song X
    Oncol Rep; 2012 Jun; 27(6):2010-6. PubMed ID: 22427141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.